Canada Rx Weekly | Oct 12, 2026 Edition

Welcome to CanadaRx Weekly

Oct 12, 2026 Edition 

Canada Rx Weekly is your Monday signal check: a fast, insight-driven run-through of the companies, clinical milestones, investments, and deals shaping Canada's biopharma landscape.

Mint Adds Four Bayer Medicines to Distribution Deal

Tevimbra Advances Toward Canadian Reimbursement

Enoumena, AOP Health Partner to Expand Sibboran Access

Canada's Biotech,

Decoded Weekly!

Canada's Biopharma. One Weekly Briefing! 

Weekly Highlights

Mint Pharmaceuticals Expands Distribution Partnership with Bayer Canada

Mint Pharmaceuticals expanded its distribution partnership with Bayer Canada to include Angeliq, Climara 25/50/75, Triquilar 21/28, and Xarelto granules for oral suspension. The agreement builds on their existing collaboration for Adalat XL (nifedipine), broadening the partnership across cardiovascular, women's health, and other therapeutic areas. Mint will leverage its nationwide distribution network and supply-chain capabilities to support reliable supply and continuity of access to Bayer's established medicines for Canadian patients and healthcare professionals.

Canada Rx Weekly | Oct 12, 2026 Edition

Keep reading

More issues

Canada Rx Weekly | Oct 19, 2026 Edition

Canada Rx Weekly | Oct 05, 2026 Edition